Business Description
Olympus Corp
ISIN : US68163W1099
Share Class Description:
OLYMY: ADR - UnsponsoredDescription
Olympus Corp manufactures and sells precision instruments for the healthcare industry. The firm operates in three segments: scientific solutions, imaging, and medical. The scientific solutions segment sells microscopes and other imaging tools to life sciences and industrial customers. The imaging segment sells digital cameras under the Olympus brand. The medical segment supplies medical equipment, including gastrointestinal and surgical endoscopes and endotherapy devices. This segment generates the vast majority of revenue. Sales in Asia and North America contribute the largest proportions of revenue.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.17 | |||||
| Equity-to-Asset | 0.49 | |||||
| Debt-to-Equity | 0.4 | |||||
| Debt-to-EBITDA | 2.67 | |||||
| Interest Coverage | 4.27 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 3.7 | |||||
| Beneish M-Score | -1.76 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.7 | |||||
| 3-Year EBITDA Growth Rate | -6.1 | |||||
| 3-Year EPS without NRI Growth Rate | -24.6 | |||||
| 3-Year Book Growth Rate | 28.4 | |||||
| Future 3-5Y Total Revenue Growth Rate | 5.74 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 80.98 | |||||
| 9-Day RSI | 76.81 | |||||
| 14-Day RSI | 71.6 | |||||
| 6-1 Month Momentum % | -1.5 | |||||
| 12-1 Month Momentum % | -21.16 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.85 | |||||
| Quick Ratio | 1.41 | |||||
| Cash Ratio | 0.81 | |||||
| Days Inventory | 211.3 | |||||
| Days Sales Outstanding | 68.19 | |||||
| Days Payable | 68.14 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Dividend Growth Rate | -6.5 | |||||
| 3-Year Average Share Buyback Ratio | 3.2 | |||||
| Shareholder Yield % | 2.88 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 66.77 | |||||
| Operating Margin % | 4.7 | |||||
| Net Margin % | 25.91 | |||||
| FCF Margin % | -2.78 | |||||
| ROE % | 31.25 | |||||
| ROA % | 15.52 | |||||
| ROIC % | 3.1 | |||||
| ROC (Joel Greenblatt) % | 13.28 | |||||
| ROCE % | 4.05 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 11.56 | |||||
| PE Ratio without NRI | 103.42 | |||||
| Shiller PE Ratio | 42.18 | |||||
| Price-to-Owner-Earnings | 12.94 | |||||
| PEG Ratio | 9.49 | |||||
| PS Ratio | 3.24 | |||||
| PB Ratio | 3.84 | |||||
| Price-to-Tangible-Book | 6 | |||||
| Price-to-Operating-Cash-Flow | 66.87 | |||||
| EV-to-EBIT | 56.07 | |||||
| EV-to-Forward-EBIT | 14 | |||||
| EV-to-EBITDA | 23.44 | |||||
| EV-to-Forward-EBITDA | 10.93 | |||||
| EV-to-Revenue | 2.84 | |||||
| EV-to-Forward-Revenue | 3.07 | |||||
| EV-to-FCF | -128.93 | |||||
| Price-to-Projected-FCF | 2.86 | |||||
| Price-to-DCF (Earnings Based) | 6.03 | |||||
| Price-to-Median-PS-Value | 1.51 | |||||
| Price-to-Peter-Lynch-Fair-Value | 9.32 | |||||
| Price-to-Graham-Number | 5.49 | |||||
| Price-to-Net-Current-Asset-Value | 123.31 | |||||
| Earnings Yield (Greenblatt) % | 1.78 | |||||
| FCF Yield % | -0.95 | |||||
| Forward Rate of Return (Yacktman) % | 13.61 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:OLYMY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Olympus Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 6,417.031 | ||
| EPS (TTM) ($) | 1.387 | ||
| Beta | 0.7 | ||
| Volatility % | 26.2 | ||
| 14-Day RSI | 71.6 | ||
| 14-Day ATR ($) | 0.404783 | ||
| 20-Day SMA ($) | 14.46741 | ||
| 12-1 Month Momentum % | -21.16 | ||
| 52-Week Range ($) | 11.91 - 16.6933 | ||
| Shares Outstanding (Mil) | 1,165.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Olympus Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Olympus Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Olympus Corp Frequently Asked Questions
What is Olympus Corp(OLYMY)'s stock price today?
The current price of OLYMY is $16.03. The 52 week high of OLYMY is $16.69 and 52 week low is $11.91.
When is next earnings date of Olympus Corp(OLYMY)?
The next earnings date of Olympus Corp(OLYMY) is 2024-05-31 Est..
Does Olympus Corp(OLYMY) pay dividends? If so, how much?
Olympus Corp(OLYMY) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers